NEW YORK (Reuters Health) – The majority of women who become pregnant after in vitro fertilization (IVF) receives progesterone throughout the first trimester, but that may not be…
NEW YORK (Reuters Health) – A new study provides more evidence that influenza vaccine reduces major cardiovascular events in patients hospitalized for acute coronary syndrome (ACS). In the…
Did you miss ePharma Summit 2011 in New York, NY? Don’t worry, The Doctor’s Channel has you covered. Get all of the highlights from the meeting right here.…
David Pogue, Tech Columnist for The New York Times, talks about new apps and gadgets for doctors. For more information on David’s Tech Blog, please visit: Pogue.Blogs.NYTimes.com For…
Peter Diamandis, MD, Founder and Chairman of the X PRIZE Foundation, talks about accelerating technologies in healthcare and the practice of medicine. For more information on the X…
NEW YORK (Reuters Health) – Among women treated for early, endocrine-responsive breast cancer, adjuvant therapy with the aromatase inhibitor letrozole leads to better overall survival than does tamoxifen,…
NEW YORK (Reuters Health) -– A point-of-care test for beta-hydroxybutyrate in capillary blood is more specific than a urine dipstick for ketones in identifying diabetic ketoacidosis in emergency-department…
NEW YORK (Reuters Health) – Treating high-risk retinopathy of prematurity (ROP) early, before threshold severity is reached, preserves peripheral vision with relatively little reduction in visual field extent.…
NEW YORK (Reuters Health) – Ribavirin added to pegylated interferon more than doubles the sustained viral response rate in children with chronic hepatitis C, a multicenter team reports…
NEW YORK (Reuters health) – The effects of cardiac resynchronization may be more dramatic in patients with advanced heart failure, but those with less severe symptoms also benefit…
NEW YORK (Reuters Health) – When oral rehydration is problematic, nasogastric administration of fluids is a good alternative for treating dehydrated children in resource-scarce settings, according to a…
NEW YORK (Reuters Health) – For initial treatment of HIV-1 infection, once daily atazanavir plus ritonavir and once-daily efavirenz provide comparable antiviral efficacy when used with either abacavir/lamivudine…
